• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

终末期肝病患者接受肝移植时的肝和心脏铁过载。

Hepatic and cardiac iron overload among patients with end-stage liver disease referred for liver transplantation.

机构信息

Division of Gastroenterology and Hepatology, Department of Medicine, Oregon Health and Science University and the Portland Veterans Affairs Medical Center, Portland, OR 97219, USA.

出版信息

Clin Transplant. 2010 Sep-Oct;24(5):643-51. doi: 10.1111/j.1399-0012.2009.01136.x.

DOI:10.1111/j.1399-0012.2009.01136.x
PMID:19925473
Abstract

BACKGROUND

Iron overload is associated with fatal cardiovascular events following liver transplantation. Myocardial iron deposits were observed post-mortem in patients who died of cardiac events after transplantation at our institution. This observation prompted testing to exclude cardiac iron in subsequent transplant candidates.

AIMS

To assess the results of testing for iron overload in liver transplant candidates at our institution.

METHODS

Ferritin, TIBC, and serum iron were measured in cirrhotics referred for transplantation. Patients with transferrin saturation ≥50% and ferritin ≥250 ng/mL underwent liver biopsy graded for iron. Patients with 3-4+ hepatic iron deposits underwent HFE mutation analysis and endomyocardial biopsy with iron staining.

RESULTS

Eight hundred and fifty-six patients were evaluated for liver transplantation between January 1997 and March 2005. Two hundred and eighty-seven patients (34%) had transferrin saturation ≥50% and ferritin ≥250 ng/mL. Patients with markers of iron overload had more advanced liver disease than those with normal iron indices. One hundred and fifty-three patients underwent liver biopsy. Twenty-six patients (17%) had 3-4+ hepatic iron staining. One patient was a C282Y heterozygote. Endomyocardial biopsy was performed in 14 patients of whom nine had cardiac iron deposition.

CONCLUSIONS

Non-HFE-related cardiac iron overload can occur in advanced liver disease We therefore recommend screening for cardiac iron prior to liver transplantation.

摘要

背景

铁过载与肝移植后致命心血管事件有关。在我们机构,接受移植后死于心脏事件的患者在死后的心肌中观察到铁沉积。这一观察结果促使我们对随后的移植候选者进行铁过载检测。

目的

评估我们机构肝移植候选者铁过载检测的结果。

方法

对接受移植的肝硬化患者进行铁蛋白、总铁结合力和血清铁检测。转铁蛋白饱和度≥50%且铁蛋白≥250ng/ml 的患者行肝脏活检评估铁含量。肝内铁沉积 3-4+的患者行 HFE 基因突变分析和心肌活检铁染色。

结果

1997 年 1 月至 2005 年 3 月期间,对 856 名患者进行了肝移植评估。287 名患者(34%)转铁蛋白饱和度≥50%且铁蛋白≥250ng/ml。铁过载标志物阳性患者的肝脏疾病比铁指数正常患者更为严重。153 名患者行肝活检,26 名患者(17%)肝内铁染色 3-4+。1 名患者为 C282Y 杂合子。14 名患者行心肌活检,其中 9 名患者有心脏铁沉积。

结论

非 HFE 相关的心脏铁过载可发生于晚期肝病患者中。因此,我们建议在进行肝移植前筛查心脏铁。

相似文献

1
Hepatic and cardiac iron overload among patients with end-stage liver disease referred for liver transplantation.终末期肝病患者接受肝移植时的肝和心脏铁过载。
Clin Transplant. 2010 Sep-Oct;24(5):643-51. doi: 10.1111/j.1399-0012.2009.01136.x.
2
Hemochromatosis and iron-overload screening in a racially diverse population.不同种族人群中的血色素沉着症和铁过载筛查
N Engl J Med. 2005 Apr 28;352(17):1769-78. doi: 10.1056/NEJMoa041534.
3
Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry.肝铁过载患者肝移植后的生存率:国家血色素沉着症移植登记处
Gastroenterology. 2005 Aug;129(2):494-503. doi: 10.1016/j.gastro.2005.05.004.
4
Iron-overload-related disease in HFE hereditary hemochromatosis.HFE 遗传性血色素沉着症中与铁过载相关的疾病。
N Engl J Med. 2008 Jan 17;358(3):221-30. doi: 10.1056/NEJMoa073286.
5
Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.德国一大群人中铁状态与遗传性血色素沉着症(密码子C282Y)之间的相关性。
Isr Med Assoc J. 2004 Jan;6(1):30-3.
6
Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.遗传性血色素沉着症的基因型与表型之间的相关性:61例分析。
Blood Cells Mol Dis. 1997 Aug;23(2):314-20. doi: 10.1006/bcmd.1997.0148.
7
Hepatic iron loading in patients with compound heterozygous HFE mutations.复合杂合子HFE突变患者的肝脏铁负荷
Liver Int. 2004 Dec;24(6):631-6. doi: 10.1111/j.1478-3231.2004.0953.x.
8
Iron overload in cirrhosis-HFE genotypes and outcome after liver transplantation.肝硬化中的铁过载——HFE基因分型与肝移植后的结局
Hepatology. 2000 Feb;31(2):456-60. doi: 10.1002/hep.510310227.
9
HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.遗传性血色素沉着症基因突变、肝脏铁含量与肝纤维化:非酒精性脂肪性肝炎与C282Y的种族特异性关联,而非与纤维化严重程度的关联。
Hepatology. 2002 Jul;36(1):142-9. doi: 10.1053/jhep.2002.33892.
10
Hepatic iron overload in alcoholic end-stage liver disease is associated with iron deposition in other organs in the absence of HFE-1 hemochromatosis.酒精性终末期肝病中的肝脏铁过载与在无HFE-1血色素沉着症情况下其他器官中的铁沉积相关。
Liver Int. 2005 Jun;25(3):513-7. doi: 10.1111/j.1478-3231.2005.01004.x.

引用本文的文献

1
[Cirrhotic cardiomyopathy – Clinically fact or academic curiosity? Review. Part 2: ECG, functional tests, images, biomarkers, screening for coronary heart disease and differentianting diagnosis].[肝硬化性心肌病——临床事实还是学术好奇?综述。第2部分:心电图、功能测试、影像学、生物标志物、冠心病筛查及鉴别诊断]
Rev Fac Cien Med Univ Nac Cordoba. 2024 Jun 28;81(2):432-452. doi: 10.31053/1853.0605.v81.n2.44419.
2
Cardiomyopathy in cirrhosis: From pathophysiology to clinical care.肝硬化中的心肌病:从病理生理学到临床护理
JHEP Rep. 2023 Sep 23;6(1):100911. doi: 10.1016/j.jhepr.2023.100911. eCollection 2024 Jan.
3
Secondary Iron Overload and the Liver: A Comprehensive Review.
继发性铁过载与肝脏:综述
J Clin Transl Hepatol. 2023 Aug 28;11(4):932-941. doi: 10.14218/JCTH.2022.00420. Epub 2023 Feb 1.
4
Sudden Onset Iron Overload Cardiomyopathy After Liver Transplantation.肝移植后突发铁过载性心肌病。
J Investig Med High Impact Case Rep. 2023 Jan-Dec;11:23247096231159812. doi: 10.1177/23247096231159812.
5
Cardiac Imaging in Liver Transplantation Candidates: Current Knowledge and Future Perspectives.肝移植候选者的心脏成像:当前认知与未来展望
J Clin Med. 2019 Dec 3;8(12):2132. doi: 10.3390/jcm8122132.
6
Cardiac MRI T2* in Liver Transplant Candidates: Application and Performance of a Novel Imaging Technique to Identify Patients at Risk for Poor Posttransplant Cardiac Outcomes.肝移植候选者的心脏磁共振成像T2*:一种用于识别移植后心脏预后不良风险患者的新型成像技术的应用与性能
Transplant Direct. 2018 Jun 8;4(7):e363. doi: 10.1097/TXD.0000000000000803. eCollection 2018 Jul.
7
Cardiac failure after liver transplantation requiring a biventricular assist device.肝移植后发生心力衰竭,需要双心室辅助装置。
Case Rep Transplant. 2014;2014:946961. doi: 10.1155/2014/946961. Epub 2014 Nov 9.